Pharmain Corporation

Akiko Nishimoto-Ashfield

Gerardo M Castillo

Elijah M Bolotin

Christian Ventocilla

Han Jiang

Yao Yao

The present disclosure provides novel V1a partial agonists for partially activating a V1a receptor. The partial V1a agonist has a therapeutic index of at least 20 (e.g., at least 30, at least 40, at least 50, at least 60, at least 70, at least 80, at least 90, at least 100). Also provided are method of treating liver fibrosis, cirrhosis, portal hypertension, ascites, esophageal varices, fundal varices, bleeding, arterial hypotension, and/or hepatorenal syndrome, including administering to a subject in need thereof a therapeutically effective dose of a composition including the V1a partial agonist(s) of the present disclosure, optionally in combination with a V2 antagonist.

Growing community of inventors

Seattle, WA, United States of America

Akiko Nishimoto-Ashfield